Encompass Health (EHC) Cash from Investing Activities (2009 - 2026)

Encompass Health (EHC) has 18 years of Cash from Investing Activities data on file, last reported at -$150.1 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 5.3% year-over-year to -$150.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$756.2 million (down 10.86% YoY) and the FY2025 annual result came in at -$764.6 million, down 17.04% from the prior year.
• Cash from Investing Activities climbed to -$150.1 million in Q1 2026, from -$239.4 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of -$104.0 million in Q1 2023 to a low of -$239.4 million in Q4 2025.
• A 5-year average of -$164.6 million and a median of -$161.5 million in 2024 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 45.49% in 2022, down 40.56% in 2022.
• Tracing EHC's Cash from Investing Activities over 5 years: stood at -$206.4 million in 2022, then slipped by 0.82% to -$208.1 million in 2023, then climbed by 2.11% to -$203.7 million in 2024, then retreated by 17.53% to -$239.4 million in 2025, then jumped by 37.3% to -$150.1 million in 2026.
• The last three Cash from Investing Activities figures came in at -$150.1 million (Q1 2026), -$239.4 million (Q4 2025), and -$201.3 million (Q3 2025), per Business Quant data.